Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
Category: Providers
In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...] …
At the start of 2024, Michigan 340B hospitals can bill the state at higher payment rates for outpatient drugs; later [...] …
Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...] …
The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...] …
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...] …
Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...] …
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...] …
Lawmakers on a key House committee approved a pharmacy benefit manager (PBM) transparency bill on Wednesday that would require PBMs [...] …